Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mohammad A. Obeid, Teeranun Teeravatcharoenchai, David Connell, Kanidta Niwasabutra, Muattaz Hussain, Katharine Carter & Valerie A. Ferro. (2021) Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. Journal of Liposome Research 31:2, pages 195-202.
Read now
Read now
Shane C McAllister & Mark R Schleiss. (2014) Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Review of Vaccines 13:11, pages 1349-1360.
Read now
Read now
Sergio Rosales-Mendoza & Jorge A Salazar-González. (2014) Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Review of Vaccines 13:6, pages 737-749.
Read now
Read now
Sergio Rosales-Mendoza. (2013) Future directions for the development of Chlamydomonas-based vaccines. Expert Review of Vaccines 12:9, pages 1011-1019.
Read now
Read now
Articles from other publishers (35)
Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin & Gerrit Borchard. (2023) Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines. Pharmacological Research 189, pages 106699.
Crossref
Crossref
Jenny Lorena Molina Estupiñan, Audur Anna Aradottir Pind, Poorya Foroutan Pajoohian, Ingileif Jonsdottir & Stefania P. Bjarnarson. (2023) The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice. Frontiers in Immunology 13.
Crossref
Crossref
Valerie S. Forsyth, Stephanie D. Himpsl, Sara N. Smith, Christina A. Sarkissian, Laura A. Mike, Jolie A. Stocki, Anna Sintsova, Christopher J. Alteri & Harry L. T. Mobley. (2020) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection. mBio 11:2.
Crossref
Crossref
Shiran Ferber, Rodrigo J. Gonzalez, Alexander M. Cryer, Ulrich H. Andrian & Natalie Artzi. (2019) Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines. Advanced Materials 32:13, pages 1903847.
Crossref
Crossref
Jorge Alberto S. Moreno, Danai-Anastasia Panou, Karen Stephansen, Ioannis S. Chronakis, Anja Boisen, Ana C. Mendes & Line Hagner Nielsen. (2018) Preparation and Characterization of an Oral Vaccine Formulation Using Electrosprayed Chitosan Microparticles. AAPS PharmSciTech 19:8, pages 3770-3777.
Crossref
Crossref
Christoffer von Halling Laier, Blake Gibson, Marco van de Weert, Ben J. Boyd, Thomas Rades, Anja Boisen, Sarah Hook & Line Hagner Nielsen. (2018) Spray dried cubosomes with ovalbumin and Quil-A as a nanoparticulate dry powder vaccine formulation. International Journal of Pharmaceutics 550:1-2, pages 35-44.
Crossref
Crossref
Jorge Alberto S. Moreno, Ana C. Mendes, Karen Stephansen, Christoph Engwer, Francisco M. Goycoolea, Anja Boisen, Line Hagner Nielsen & Ioannis S. Chronakis. (2018) Development of electrosprayed mucoadhesive chitosan microparticles. Carbohydrate Polymers 190, pages 240-247.
Crossref
Crossref
V. Busignies, G. Simon, G. Mollereau, O. Bourry, V. Mazel, M. Rosa-Calatrava & P. Tchoreloff. (2018) Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study. International Journal of Pharmaceutics 538:1-2, pages 87-96.
Crossref
Crossref
Man Li, You Li, Ke Peng, Ying Wang, Tao Gong, Zhirong Zhang, Qin He & Xun Sun. (2017) Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses. Acta Biomaterialia 64, pages 237-248.
Crossref
Crossref
Line Hagner Nielsen, Thomas Rades, Ben Boyd & Anja Boisen. (2017) Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. European Journal of Pharmaceutics and Biopharmaceutics 118, pages 13-20.
Crossref
Crossref
Matilde Merlin, Mario Pezzotti & Linda Avesani. (2017) Edible plants for oral delivery of biopharmaceuticals. British Journal of Clinical Pharmacology 83:1, pages 71-81.
Crossref
Crossref
N. Woods, K. Niwasabutra, R. Acevedo, J. Igoli, N.A. Altwaijry, J. Tusiimire, A.I. Gray, D.G. Watson & V.A. Ferro. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
211
229
.
Imad Al KassaaBachar ISMAIL. 2017. New Insights on Antiviral Probiotics. New Insights on Antiviral Probiotics
47
60
.
Ning Wang & Ting Wang. 2016. Vaccine Design. Vaccine Design
635
649
.
Aleksandra Inic-Kanada, Marijana Stojanovic, Simone Schlacher, Elisabeth Stein, Sandra Belij-Rammerstorfer, Emilija Marinkovic, Ivana Lukic, Jacqueline Montanaro, Nadine Schuerer, Nora Bintner, Vesna Kovacevic-Jovanovic, Ognjen Krnjaja, Ulrike Beate Mayr, Werner Lubitz & Talin Barisani-Asenbauer. (2015) Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers. PLOS ONE 10:12, pages e0144380.
Crossref
Crossref
Tie-E Zhang, Li-Tian Yin, Run-Hua Li, Hai-Long Wang, Xiao-Li Meng & Guo-Rong Yin. (2015) Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice. Parasites & Vectors 8:1.
Crossref
Crossref
Darrell J. Irvine, Melissa C. Hanson, Kavya Rakhra & Talar Tokatlian. (2015) Synthetic Nanoparticles for Vaccines and Immunotherapy. Chemical Reviews 115:19, pages 11109-11146.
Crossref
Crossref
Ekaterini Tiligada, Masaru Ishii, Carlo Riccardi, Michael Spedding, Hans-Uwe Simon, Mauro Martins Teixeira, Mario Landys Chovel Cuervo, Stephen T Holgate & Francesca Levi-Schaffer. (2015) The expanding role of immunopharmacology: IUPHAR Review 16. British Journal of Pharmacology 172:17, pages 4217-4227.
Crossref
Crossref
Huub Savelkoul, Valerie Ferro, Marius Strioga & Virgil Schijns. (2015) Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines. Vaccines 3:1, pages 148-171.
Crossref
Crossref
Peter Michael Moyle. (2015) Progress in Vaccine Development. Current Protocols in Microbiology 36:1.
Crossref
Crossref
Deborah A. Garside, Reinaldo Acevedo, Manal Alsaadi, Natalie Nimmo, Ayman Gebril, Dimitrios Lamprou, Alexander B. Mullen & Valerie A. Ferro. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
221
250
.
Shailbala Singh, Guojun Yang, Siddappa N. Byrareddy, Michael A. Barry & K. Jagannadha Sastry. (2014) Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. Vaccine 32:51, pages 6934-6940.
Crossref
Crossref
Shailbala Singh, Pramod Nehete, Guojun Yang, Hong He, Bharti Nehete, Patrick Hanley, Michael Barry & K. Sastry. (2014) Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines 2:4, pages 686-706.
Crossref
Crossref
Yuhong Jiang, Man Li, Zhirong Zhang, Tao Gong & Xun Sun. (2014) Enhancement of Nasal HIV Vaccination with Adenoviral Vector-Based Nanocomplexes Using Mucoadhesive and DC-Targeting Adjuvants. Pharmaceutical Research 31:10, pages 2748-2761.
Crossref
Crossref
Heleen Kraan, Hilde Vrieling, Cecil Czerkinsky, Wim Jiskoot, Gideon Kersten & Jean-Pierre Amorij. (2014) Buccal and sublingual vaccine delivery. Journal of Controlled Release 190, pages 580-592.
Crossref
Crossref
Ning Wang, Ting Wang, Meiling Zhang, Ruonan Chen, Ruowen Niu & Yihui Deng. (2014) Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 194-206.
Crossref
Crossref
Iskra Tuero & Marjorie Robert-Guroff. (2014) Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models. Viruses 6:8, pages 3129-3158.
Crossref
Crossref
Vincent Pavot, Nicolas Rochereau, Philip Lawrence, Marc P. Girard, Christian Genin, Bernard Verrier & Stéphane Paul. (2014) Recent progress in HIV vaccines inducing mucosal immune responses. AIDS 28:12, pages 1701-1718.
Crossref
Crossref
Ayman M. Gebril, Dimitrios A. Lamprou, Manal M. Alsaadi, William H. Stimson, Alexander B. Mullen & Valerie A. Ferro. (2014) Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 10:5, pages e971-e979.
Crossref
Crossref
Ning Wang, Ting Wang, Meiling Zhang, Ruonan Chen & Yihui Deng. (2014) Using procedure of emulsification–lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS). International Journal of Pharmaceutics 468:1-2, pages 39-49.
Crossref
Crossref
Elke Bergmann-Leitner & Wolfgang Leitner. (2014) Adjuvants in the Driver’s Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators. Vaccines 2:2, pages 252-296.
Crossref
Crossref
Rebecca M. Brotman, Jacques Ravel, Patrik M. Bavoil, Patti E. Gravitt & Khalil G. Ghanem. (2014) Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections. Vaccine 32:14, pages 1543-1552.
Crossref
Crossref
Dania O. Govea-Alonso, Edward Rybicki & Sergio Rosales-Mendoza. 2014. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases
265
280
.
Talin Barisani-Asenbauer, Aleksandra Inic-Kanada, Sandra Belij, Emilija Marinkovic, Ivana Stojicevic, Jacqueline Montanaro, Elisabeth Stein, Nora Bintner & Marijana Stojanovic. (2013) The Ocular Conjunctiva as a Mucosal Immunization Route: A Profile of the Immune Response to the Model Antigen Tetanus Toxoid. PLoS ONE 8:4, pages e60682.
Crossref
Crossref
Reid A. Roberts, Tammy Shen, Irving C. Allen, Warefta Hasan, Joseph M. DeSimone & Jenny P. Y. Ting. (2013) Analysis of the Murine Immune Response to Pulmonary Delivery of Precisely Fabricated Nano- and Microscale Particles. PLoS ONE 8:4, pages e62115.
Crossref
Crossref